Genomic characterisation of a lytic Vectrevirus phage Eco-MTCMU-01 targeting ESBL-producing E. coli
The emergence of ESBL-producing Escherichia coli poses a significant threat to global public health due to its resistance to a broad range of beta-lactam antibiotics. One of these solutions is treating bacterial infections with bacteriophage, known as phage therapy. This study focuses on the isolation and characterisation of a novel lytic bacteriophage targeting ESBL-producing E. coli. The bacteriophage was isolated from sewage samples in Bangkok, Thailand.
The emergence of ESBL-producing Escherichia coli poses a significant threat to global public health due to its resistance to a broad range of beta-lactam antibiotics. One of these solutions is treating bacterial infections with bacteriophage, known as phage therapy. This study focuses on the isolation and characterisation of a novel lytic bacteriophage targeting ESBL-producing E. coli. The bacteriophage was isolated from sewage samples in Bangkok, Thailand.
Faculty of Pharmacy Mahidol University